22-25 March 2026
With more than 80 years of toxicology experience, Labcorp is focused on delivering the answers you need to move your program to the next milestone. Our global capacity, flexible scheduling and rapid study initiation creates a streamlined approach to nonclinical services, which means successful design and execution of your program across discovery, safety pharmacology, toxicology, pathology, bioanalysis, drug metabolism and pharmacokinetics.
Propel your development program with our comprehensive toxicology solutions
General to specialty
Small and large animal models
All routes of administration
Small and large molecule, cell and gene therapies
Meet our team at SOT
Booth #1205
Our commercial and scientific team members will be on-site to provide comprehensive and strategic insights to help reduce risk and move your program more efficiently across critical milestones.
Our presence
Exhibitor hosted sessions
Biocidal Product Regulation: Integration of Neurobehavioral Endpoints into OECD 426 and 443 Studies
Monday, March 23 | 9:15 AM – 10:15 AM | Room 23C
This session will highlight developmental neurotoxicity aspects of OECD 443 and 426, focusing on differences in neurobehavioral requirements under the Biocidal Products Regulation (BPR). Key BPR-specific endpoints such as egocentric learning (Cincinnati Water Maze) and motor/anxiety behavior (Open Field Test) will be discussed by Dilshan Harischandra and Sarah Beck from Labcorp, with industry insights included.
From Chips to Controls: Transforming Product Development with NAMs to Advance the 3Rs
Wednesday, March 25 | 3:15 PM – 4:15 PM | Room 23C
Labcorp is advancing regulatory testing through development and evaluation of NAMs. This session will highlight ongoing initiatives, including developing simple and more complex organ-on-a-chip models of immunity as well as Virtual Control Group collaborations with industry. Expert scientists will present current progress, and industry insights on applying Advanced Cell Models to enhance human safety predictions will be shared.
Posters
|
Session Date & Time |
Presenting Author |
Title |
Details |
|
Monday March 23, 2026 |
|||
|
|
Abha Aggarwal |
Importance of extraction vessel shape in medical device testing: a GeneTox case report |
Abstract # 3069 |
|
|
Dilshan Harischandra |
Cross-Laboratory Reproducibility and Age-Adapted Strategies for Learning and Memory Assessment in Rodents Using Morris and Biel Water Maze Paradigms |
Abstract #3218 |
|
|
Hayley Myles |
In life low-volume sampling and bioanalysis of thyroid hormones on a short-term mode of action study in Han Wistar rats: 6-PTU case study |
|
|
|
Stephen Brewin |
Thyroxine (T4) and Triiodothyronine (T3): Validation of Methodology for the Determination of Concentrations in Surrogate Matrix and Serum Using Low Sample Volumes |
Abstract # 3286 |
|
|
Michael Hollings |
Optimizing Air-Liquid Interface Respiratory NAM Models for Acute Exposure Scenarios to Support Regulatory Screening and Safety Assessment |
Abstract # 3377 |
|
1:45 PM - 4:15 PM |
Michael Oldham |
Clinically Relevant Doses for Electronic Nicotine Delivery System and Heated Tobacco Product In Vitro Testing |
Abstract # 3456 |
|
1:45 PM - 4:15 PM |
Simon Moore |
Using computational fluid dynamics to estimate the efficiency of dosing by varying the respiration rate and tidal volume of the rat and changing the position of the rat snout using an inhalation directed flow chamber |
Abstract # 3509 |
|
1:45 PM - 4:15 PM |
Joseph Jilek |
Inhalation route of administration imparts greater variability in systemic toxicokinetics dependent upon molecular class |
Abstract # 3522 |
|
1:45 PM - 4:15 PM |
David Mayfield |
Safety Evaluation of a Sugar Replacement (Honey Truffle Sweet Protein) Derived from Nature |
Abstract # 3651 |
|
1:45 PM - 4:15 PM |
Sarah Beck |
The Functional Observational Battery in Rats - Results from a Positive Control Study to Support Crop Protection and Chemical Safety Studies |
Abstract # 3219 |
|
Tuesday March 24, 2026 |
|||
|
9:15 AM - 11:45 AM |
Laura Wieczorkiewicz |
Timing of Artifactual Erythrocyte Morphologic Changes Associated with Storage of Blood in Common Laboratory Animal Species |
Abstract # 3849 |
|
9:15 AM - 11:45 AM |
Yong Pu |
Comparative Assessment of Oral Gavage, Intravenous, and Subcutaneous Dosing Routes on Maternal Body Weight and Food Consumption in Rabbit Embryo-Fetal Development Studies |
Abstract # 3866 |
|
1:45 PM - 4:15 PM |
Julia Detert |
Formalin-Fixed, Paraffin-Embedded (FFPE) Tissues for Retrospective Transgenic Mouse (rasH2) Genotyping |
Abstract # 3760 |
|
1:45 PM - 4:15 PM |
Changqing Zhou |
Evaluation of Data Inclusion of Dams with No Viable Fetuses in Maternal Data Analysis in Rat Embryo-Fetal Development Studies |
Abstract # 3821 |
|
1:45 PM - 4:15 PM |
Tomoya Yamada |
Rodent Liver Tumors Produced by Activators of the Constitutive Androstane Receptor (CAR) and the Peroxisome Proliferator-Activated Receptor Alpha (PPARα) are Not Relevant to Human Cancer Risk |
Abstract # 4291 |
|
Wednesday March 25, 2026 |
|||
|
1:45 PM - 4:15 PM |
Jone Stanley |
Comprehensive reference values for clinical pathology parameters in cynomolgus monkeys (Macaca fascicularis) |
Abstract # 5146 |
|
1:45 PM - 4:15 PM |
Kaitlin Reeves |
Application of surrogate matrices in PCR-based method development and validation |
Abstract # 5226 |
|
1:45 PM - 4:15 PM |
Darren Kidd |
The devTOX quickPredictTM assay: A high reproducible in vitro NAM for developmental toxicity prediction as demonstrated by an interlaboratory blinded study |
Abstract # 5229 |
Learn more at labcorp.com/biopharma/nonclinical.
Labcorp respects your privacy.
Manage your subscriptions.
© 2025 Laboratory Corporation of America® Holdings. All Rights Reserved.